Characterizing human regulatory genetic variation using CRISPR/Cas9 genome editing

Rare gene-disrupting variants and common regulatory variants play key roles in rare and common disease, respectively. These variants are of great interest for investigation into genetic contributions to disease, but experimental methods to validate their impact on gene expression levels are lacking. In this study, we utilized CRISPR/Cas9 genome editing to validate regulatory variants including cis-eQTLs, rare stop-gained variants in healthy and disease cases and one immune-response trans-eQTL master regulator. For investigation into common and rare regulatory variants within transcribed regions, we developed a scalable CRISPR-based polyclonal assay for experimental assessment. First, we applied this assay to nine rare stop-gained variants found in the general population, in GTEx. After editing, the stop-gained variants show a significant allele-specific depletion in transcript abundance, as expected. Next, we utilized the assay to validate 33 common eQTLs found in GTEx. After editing, the eQTL variants show higher variance in effect size than control variants, indicating a regulatory effect. Finally, we applied the polyclonal editing approach to clinical and new stop-gained variants in two disease-associated genes. The results follow the expected trend, with NMD being triggered by variants upstream of the NMD threshold but not by those beyond. This method demonstrates scalable experimental confirmation of putative causal regulatory variants, and improved interpretation of regulatory variation in humans. Next, we sought to experimentally validate an immune-response eQTL for IRF1 in cis and many genes in trans under LPS stimulation. We used CRISPRi to repress the enhancer locus and found that the enhancer is active in our immune cell system. Next, we used CRISPR-Cas9 genome editing and isolation of monoclonal cell lines to target this variant locus. After LPS stimulation, we performed RNA-sequencing on wild type and edited clones, showing that the effect size of the genes which are associated with the trans-eQTL are correlated with differential expression between the edited and wild type cell lines for the same genes. Additionally, we find that the differential expression between edited clones is correlated with CRISPRi repression of the IRF1 promoter and enhancer. In this way, we were able to identify a common genetic variant which modifies the transcriptomic immune response to LPS and validate the trans-eQTL signal

A polyclonal allelic expression assay for detecting regulatory effects of transcript variants

We present an assay to experimentally test the regulatory effects of genetic variants within transcripts using CRISPR/Cas9 followed by targeted sequencing. We applied the assay to 32 premature stop-gained variants across the genome and in two Mendelian disease genes, 33 putative causal variants of eQTLs, and 62 control variants in HEK293T cells, replicating a subset of variants in HeLa cells. We detected significant effects in the expected direction (in 60% of variants), demonstrating the ability of the assay to capture regulatory effects of eQTL variants and nonsense-mediated decay triggered by premature stop-gained variants. The results suggest a utility for validating transcript-level effects of genetic variants

Transcriptomic signatures across human tissues identify functional rare genetic variation

© 2020 American Association for the Advancement of Science. All rights reserved. INTRODUCTION: The human genome contains tens of thousands of rare (minor allele frequency 800 genomes matched with transcriptomes across 49 tissues, we were able to study RVs that underlie extreme changes in the transcriptome. To capture the diversity of these extreme changes, we developed and integrated approaches to identify expression, allele-specific expression, and alternative splicing outliers, and characterized the RV landscape underlying each outlier signal. We demonstrate that personal genome interpretation and RV discovery is enhanced by using these signals. This approach provides a new means to integrate a richer set of functional RVs into models of genetic burden, improve disease gene identification, and enable the delivery of precision genomics

Transport of Protostellar Cosmic Rays in Turbulent Dense Cores

Recent studies have suggested that low-energy cosmic rays (CRs) may be accelerated inside molecular clouds by the shocks associated with star formation. We use a Monte Carlo transport code to model the propagation of CRs accelerated by protostellar accretion shocks through protostellar cores. We calculate the CR attenuation and energy losses and compute the resulting flux and ionization rate as a function of both radial distance from the protostar and angular position. We show that protostellar cores have nonuniform CR fluxes that produce a broad range of CR ionization rates, with the maximum value being up to two orders of magnitude higher than the radial average at a given distance. In particular, the CR flux is focused in the direction of the outflow cavity, creating a flashlight effect and allowing CRs to leak out of the core. The radially averaged ionization rates are less than the measured value for the Milky Way of zeta approximate to 10(-16) s(-1); however, within r approximate to 0.03 pc from the protostar, the maximum ionization rates exceed this value. We show that variation in the protostellar parameters, particularly in the accretion rate, may produce ionization rates that are a couple of orders of magnitude higher or lower than our fiducial values. Finally, we use a statistical method to model unresolved subgrid magnetic turbulence in the core. We show that turbulence modifies the CR spectrum and increases the uniformity of the CR distribution but does not significantly affect the resulting ionization rates

Sistema Tegumentario-ME141-201802

El curso Sistema Tegumentario revisa el desarrollo estructura función y disfunción de la piel. Las actividades de aprendizaje realizan una revisión de los fundamentos del sistema tegumentario y de sus patologías más frecuentes. Curso de especialidad en la carrera de Medicina de carácter teórico práctico dirigido a los estudiantes del segundo nivel de la malla curricular busca desarrollar la competencia específica de Profesionalismo ¿ Aprendizaje autónomo y desarrollo profesional. Este curso brinda las bases de la práctica clínica y en los cursos siguientes se desarrolle la competencia de diagnóstico prevención y promoción